Strata Critical Medical, Inc.
SRTA- Exchange
- Nasdaq
- Industry
- Services-Health Services
- SEC CIK
- 0001779128
In the last 90 days, Strata Critical Medical, Inc. insiders filed 0 open-market purchases and 1 sale; 139 institutions reported holding it in 13F filings for Q2 2026, worth $281.4M in total; superinvestors Third Point and ARK Invest hold it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Strata Critical Medical, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $29.3K in total
- Insiders trading
- 1
- Net value
- −$29.3K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Strata Critical Medical, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Tomkiel Melissa M. | Co-CEO and General Counsel | 2,153,678 | Sep 25, 2026 | 12 |
| Heyburn William A. | Co-CEO and CFO | 1,757,850 | Sep 25, 2026 | 9 |
| Verdetto Louis R. | CEO, Clinical Services | 1,128,096 | Sep 10, 2026 | 2 |
| Wunsch Scott M | CEO, Logistics | 663,043 | Sep 10, 2026 | 9 |
| Cohen Amir | Chief Accounting Officer | 177,154 | Sep 10, 2026 | 11 |
| Love Reginald | Director | 146,481 | Aug 13, 2026 | 4 |
| Cook William L. III | Director | 97,671 | Aug 3, 2026 | 2 |
| Philip Edward M | Director | 265,078 | Aug 3, 2026 | 1 |
| Wiesenthal Robert S | Director | 5,325,896 | Aug 3, 2026 | 1 |
| Lauck Andrew | Director | 170,902 | Aug 3, 2026 | 2 |
| Krstic Velibor | 10% Owner | – | May 8, 2026 | 1 |
| Lerer Kenneth B | Director | 165,964 | Aug 5, 2025 | 0 |
| Lyne Susan M | Director | 187,185 | Aug 5, 2025 | 0 |
| Affeldt Eric | Director | 165,964 | Aug 5, 2025 | 0 |
| Borthwick John | Director | 203,977 | Aug 5, 2025 | 0 |
| Bacon Seth J | CEO, Trinity Air Medical | 340,785 | Jun 17, 2024 | 0 |
| Garvey Jane C | Director | 123,264 | Aug 9, 2023 | 0 |
| Keene Brandon A. | Chief Innovation Officer | 318,589 | Nov 21, 2022 | 0 |
| Arkhipenko Anatoli | Chief Technology Officer | 111,754 | Nov 14, 2022 | 0 |
| Resnick Eric Charles | 10% Owner | 0 | Jan 24, 2022 | 0 |
| Experience Sponsor LLC | 10% Owner | 0 | Jan 24, 2022 | 0 |
| Steele ExpCo Holdings, LLC | 10% Owner | 0 | Jan 24, 2022 | 0 |
| Zaslav David | Director | 45,022 | Sep 24, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2023 (view filing) | Jul 6-10 | 4 days | Heyburn William A.Chief Financial Officer | SSaleClass A common stock, $0.0001 par value per share | −83.8K | $3.82 | −$320.3K | −5.8%1.37M after | 3 lots |
| Jul 10, 2023 (view filing) | Jul 6-10 | 4 days | Tomkiel Melissa M.President and General Counsel | SSaleClass A common stock, $0.0001 par value per share | −91.1K | $3.82 | −$348.1K | −6.6%1.29M after | 3 lots |
| Apr 11, 2023 (view filing) | Apr 5-10 | 6 daysLate | Tomkiel Melissa M.President and General Counsel | SSaleClass A common stock, $0.0001 par value per share | −40.0K | $2.90 | −$115.7K | −2.8%1.40M after | 3 lots |
| Apr 11, 2023 (view filing) | Apr 5-10 | 6 daysLate | Heyburn William A.Chief Financial Officer | SSaleClass A common stock, $0.0001 par value per share | −41.5K | $2.90 | −$120.3K | −2.8%1.46M after | 3 lots |
| Apr 11, 2023 (view filing) | Apr 5-10 | 6 daysLate | Cohen AmirChief Accounting Officer | SSaleClass A common stock, $0.0001 par value per share | −5.75K | $2.90 | −$16.7K | −4.2%130.2K after | 3 lots |
| Apr 11, 2023 (view filing) | Apr 5-10 | 6 daysLate | Wiesenthal Robert SChief Executive Officer | SSaleClass A common stock, $0.0001 par value per share | −106.9K | $2.90 | −$309.6K | −1.4%7.67M after | 3 lots |
| Jan 12, 2023 (view filing) | Jan 9 | 3 daysLate | Heyburn William A.Chief Financial Officer | SSaleClass A common stock, $0.0001 par value per share | −4.31K | $3.47 | −$14.9K | −0.3%1.45M after | |
| Jan 12, 2023 (view filing) | Jan 9 | 3 daysLate | Wiesenthal Robert SChief Executive Officer | SSaleClass A common stock, $0.0001 par value per share | −10.9K | $3.47 | −$37.7K | −0.1%7.78M after | |
| Jan 12, 2023 (view filing) | Jan 9 | 3 daysLate | Tomkiel Melissa M.President and General Counsel | SSaleClass A common stock, $0.0001 par value per share | −5.14K | $3.47 | −$17.8K | −0.4%1.37M after | |
| Jan 12, 2023 (view filing) | Jan 9 | 3 daysLate | Cohen AmirChief Accounting Officer | SSaleClass A common stock, $0.0001 par value per share | −2.75K | $3.47 | −$9.53K | −2.0%136.0K after | |
| Dec 16, 2022 (view filing) | Dec 14 | 2 days | Cohen AmirChief Accounting Officer | SSaleClass A common stock, $0.0001 par value per share | −7.96K | $4.55 | −$36.2K | −5.4%138.7K after | |
| Nov 21, 2022 (view filing) | Nov 18 | 3 days | Keene Brandon A.Chief Innovation Officer | SSaleClass A common stock, $0.0001 par value per share | −29.1K | $4.79 | −$139.4K | −8.4%318.6K after | 2 lots |
| Oct 11, 2022 (view filing) | Oct 6 | 5 days | Heyburn William A.Chief Financial Officer | SSaleClass A common stock, $0.0001 par value per share | −3.74K | $3.97 | −$14.9K | −0.8%481.0K after | |
| Oct 11, 2022 (view filing) | Oct 6 | 5 days | Tomkiel Melissa M.President and General Counsel | SSaleClass A common stock, $0.0001 par value per share | −4.37K | $3.97 | −$17.3K | −1.0%423.6K after | |
| Oct 11, 2022 (view filing) | Oct 6 | 5 days | Cohen AmirChief Accounting Officer | SSaleClass A common stock, $0.0001 par value per share | −1.66K | $3.91 | −$6.49K | −2.7%59.4K after | |
| Oct 11, 2022 (view filing) | Oct 6 | 5 days | Keene Brandon A.Chief Innovation Officer | SSaleClass A common stock, $0.0001 par value per share | −1.28K | $3.97 | −$5.09K | −0.4%347.7K after | |
| Oct 11, 2022 (view filing) | Oct 6 | 5 days | Wiesenthal Robert SChief Executive Officer | SSaleClass A common stock, $0.0001 par value per share | −9.45K | $3.97 | −$37.5K | −0.2%5.42M after | |
| Sep 14, 2022 (view filing) | Sep 12-14 | 2 days | Keene Brandon A.Chief Innovation Officer | SSaleClass A common stock, $0.0001 par value per share | −50.0K | $4.79 | −$239.3K | −12.5%349.0K after | 3 lots |
| Aug 17, 2022 (view filing) | Aug 15-16 | 2 days | Lerer Kenneth BDirector | SSaleClass A common stock, $0.0001 par value per share | −63.9K | $6.31 | −$403.2K | −67.4%30.9K after | 4 lots |
| Aug 17, 2022 (view filing) | Aug 16 | 1 day | Cohen AmirChief Accounting Officer | SSaleClass A common stock, $0.0001 par value per share | −4.00K | $6.29 | −$25.2K | −6.2%61.0K after | |
| Aug 15, 2022 (view filing) | Aug 11-12 | 4 days | Lerer Kenneth BDirector | SSaleClass A common stock, $0.0001 par value per share | −264.0K | $6.47 | −$1.71M | −72.7%99.3K after | 4 lots |
| Jun 6, 2022 (view filing) | Jun 3-6 | 3 days | Lerer Kenneth BDirector | SSaleClass A common stock, $0.0001 par value per share | −66.9K | $7.05 | −$471.7K | −31.5%145.2K after | 4 lots |
| Jun 2, 2022 (view filing) | May 31-Jun 2 | 2 days | Lerer Kenneth BDirector | SSaleClass A common stock, $0.0001 par value per share | −281.3K | $7.29 | −$2.05M | −62.5%168.5K after | 6 lots |
| May 27, 2022 (view filing) | May 25-26 | 2 days | Lerer Kenneth BDirector | SSaleClass A common stock, $0.0001 par value per share | −51.0K | $7.04 | −$358.6K | −47.5%56.4K after | 2 lots |
| May 27, 2022 (view filing) | May 25-26 | 2 days | Lerer Kenneth BDirector | SSaleClass A common stock, $0.0001 par value per share | −419.7K | $7.04 | −$2.95M | −61.2%266.5K after | 6 lots |